AptaBio Therapeutics Inc. (KOSDAQ: 293780)
South Korea
· Delayed Price · Currency is KRW
6,570.00
-170.00 (-2.52%)
Dec 19, 2024, 12:30 PM KST
AptaBio Therapeutics Market Cap
AptaBio Therapeutics has a market cap or net worth of 165.59 billion as of December 20, 2024. Its market cap has decreased by -7.75% in one year.
Market Cap
165.59B
Enterprise Value
141.30B
Revenue
2.91B
Ranking
n/a
PE Ratio
n/a
Stock Price
6,570.00
Market Cap Chart
Since June 12, 2019, AptaBio Therapeutics's market cap has decreased from 423.30B to 165.59B, a decrease of -60.88%. That is a compound annual growth rate of -15.61%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Dec 20, 2024 | 165.59B | -17.95% |
Dec 28, 2023 | 201.80B | -15.02% |
Dec 29, 2022 | 237.48B | -71.24% |
Dec 30, 2021 | 825.71B | 46.50% |
Dec 30, 2020 | 563.64B | 49.70% |
Dec 30, 2019 | 376.51B | -11.05% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition